Amazon Gets Into Boner Pill Business, Hims Stock Goes Limp

Hims & Hers’ stock tumbles on Amazon’s latest disruptive foray into healthcare
Hims & Hers Health Inc. shares tumbled 22% Thursday, on concerns that Amazon.com Inc.’s latest push into healthcare will disrupt Hims & Hers’ business. Amazon One Medical launched a new service Thursday that offers upfront pricing for telehealth visits for a range of issues and ailments — including men’s hair loss,
Hims & Hers Stock Drops After Amazon Says It Will Offer Hair-Loss Treatments
Shares of Hims & Hers slid after Amazon.com said it would offer cheap treatments for concerns like hair loss, skin care and erectile dysfunction, directly competing with the telehealth startup. Amazon on Thursday launched the treatments through its One Medical telehealth service,
Amazon Gets Into the Boner Pill Business, Hims Stock Goes Limp
Amazon acquired primary care provider One Medical for $3.9 billion in 2022, and fills prescriptions through Amazon Pharmacy. Medications are packaged in standard Amazon packaging, so nobody will know you’re ordering boner pills.
Hold Rating for Hims & Hers Health Amidst Competitive Pressure from Amazon’s Telehealth Services
Citi analyst Daniel Grosslight has maintained their neutral stance on HIMS stock, giving a Hold rating on November 6. Daniel
Hims & Hers Health Stock Is Tumbling Thursday: What's Going On?
Hims & Hers Health Inc (NYSE:HIMS) shares are trading lower in possible response to Amazon.com Inc's (NASDAQ:AMZN) new upfront pricing for telehealth visits and treatment plans.
Amazon's push into telehealth knocks shares of Hims & Hers
Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits. Amazon said it is introducing low, upfront pricing for a clinical visit,
Amazon service a threat to Hims & Hers’ core offering, says Citi
After Amazon (AMZN) announced its launch of its Amazon One Medical Pay-per-visit telehealth service, which is “very similar” to
Hims & Hers stock falls as Amazon launches Telehealth offering
Shares of Hims & Hers Health, Inc. (HIMS) dropped over 15% Thursday following Amazon’s announcement of new telehealth treatment options aimed at providing low-cost care for a range of health and beauty concerns,
Hims & Hers drops 17% as Amazon rolls out expanded telehealth service
Shares of telehealth services provider Hims & Hers (NYSE:HIMS) fell 17% in morning trading Thursday after Amazon (NASDAQ:AMZN) announced it was launching an expanded pay-per-visit telehealth service,
Amazon launches fixed pricing to treat conditions like hair loss. Hims & Hers stock drops 15%
Amazon announced Prime members can access new upfront pricing to treat five common conditions like erectile disfunction and ...
Hims & Hers drops 22% on Amazon competition concerns (update)
Hims & Hers (HIMS) fell 22% after Amazon (AMZN) announced it was entering the hair loss and erectile dysfunction treatment ...
Yahoo Finance9h
Amazon launches lifestyle drug service as challenge to Hims & Hers
The move into lifestyle treatments is seen as a challenge to companies like Hims & Hers, which saw its stock value drop ...
Amazon's telehealth platform adds low-cost plans for hair loss, skin care, and more
Amazon One Medical is expanding its telehealth services with the launch of upfront and low-cost treatment plans and ...
Hims & Hers cut to underperform by BoA over Amazon competition
BofA lowered its rating of Hims & Hers (HIMS) to underperform from buy, citing Amazon’s (AMZN) push into the hair loss and ...